openPR Logo
Press release

Swine Flu - Fast and Reliable Isolation of the Viral RNA

09-10-2009 07:42 PM CET | Health & Medicine

Press release from: chemagen AG

The chemagic MSM I can be equipped with three different heads. The chemagic 96 Rod Head contains 96 steel needles for low volume samples and high throughput application whereas the chemagic 12 or 24 heads are used for large volume applications.

The chemagic MSM I can be equipped with three different heads. The chemagic 96 Rod Head contains 96 steel needles for low volume samples and high throughput application whereas the chemagic 12 or 24 heads are used for large volume applications.

Baesweiler, September 7th 2009. The growing amount of suspicious cases for swine flu in addition to the other daily samples forces diagnostic laboratories to react. They need a reliable, time saving solution to cope with a daily throughput of up to 500 additional samples per day. Besides the rising number of samples, the incoming sample material used for different diagnostic requests is very heterogeneous. Processing stool, plasma, swabs and urine in parallel is almost the only way to deal with the huge amount of daily samples. But this variety of sample materials makes it more or less impossible to automate the crucial step of nucleic acid isolation. However chemagen offers a very flexible solution to solve this problem – the chemagic Magnetic Separation Module I.

The chemagic Magnetic Separation Module I (chemagic MSM I) performs automated nucleic acid isolation within one hour. Viral RNA of 96 nasal swabs can be extracted in parallel. “We couldn’t cope with 500 additional samples per day without our chemagic MSM I.” says Dr. Andreas Lindauer, sYnlab Molecular Biology, Weiden, Germany.

chemagic Viral Kits: One for All
“We place stool suspensions, blood, plasma, serum and urine samples on a 96 well plate and isolate the nucleic acids with a generic chemagen protocol. That saves a lot of time. No cross contaminations occurred so far.” Dr. Michael Weizenegger, Labor Limbach, Heidelberg, Germany describes one of the main advantages of the chemagic MSM I: the ability to process various sample materials with one kit – the chemagic gDNA/Viral NA Kit special, which is dedicated to the use with the chemagic MSM I.

Highest Flexibility in Sample Volumes
Due to three chemagic Rod Heads – exchangeable within minutes – the chemagic MSM I is very flexible. Corresponding to standard well plates the chemagic MSM I can be equipped with a chemagic 12, 24 or 96 Rod Head. Thus sample volumes from 10 µl – 10 ml can be processed easily using only one instrument. The chemagic 96 Rod Head with 96 thin steel needles is destined for high throughput applications. Processing 96 samples with the typical volume of 200 µl to extract pathogen DNA and RNA takes only 60 minutes.

The chemagic Prepito
“Sometimes late in the afternoons we get a few urgent samples that we don’t want to process manually, in this case the chemagic Prepito is the perfect system. It can process up to 12 samples with the same efficiency as the chemagic MSM I.” says Dipl.-Biol. Christian Klos (sYnlab Weiden). This small benchtop solution facilitates NA isolation from 10 µ – 600 µl. The chemagic Prepito uses the same separation technology as the chemagic MSM I.

The chemagic Separation Technology
chemagen’s core competence is the development and production of magnetic particles for nucleic acid isolation. These proprietary M-PVA Magnetic Beads have a high affinity to nucleic acids. Both chemagic isolation platforms use this unique separation principle: A strong electromagnet magnetizes steel needles of the chemagic Rod Heads, covered with disposable tips to avoid contamination. M-PVA Magnetic Beads are attracted by these magnetized needles. Due to their DNA/RNA binding capacity, the Magnetic Beads transport the nucleic acids from one vessel to another during the whole isolation process. Lysis, mixing, binding and elution are realized through the patented rotation of the needles when the magnet is off. This technology does not lead to DNA shearing and supports an efficient binding of nucleic acids to the beads.

New subsidiary in the United States
In July 2009 chemagen AG has founded a subsidiary in the USA. Based on several years of experience in the field of Human Genetics, HLA Typing, Blood Banking and Pathogen Diagnostics the customers of chemagen USA, Inc. will benefit from this knowledge. chemagen offers highly qualified technical support and never hesitates to offer a customized solution.

chemagen’s Distribution Channels
chemagen distributes its products directly or through one of the 19 distributors all over the world. The entire list of chemagen distributors can be found at http://www.chemagen.com/distributors.html. Most partners decided for the chemagic automation to complete their portfolio offering solutions for human diagnostics. The extracted DNA/RNA is ready to use for many downstream applications such as HLA Typing, Real-Time PCR, Sequencing or Hybridisation Assays. chemagen is always looking for new distribution partners in countries that are yet not covered by their distribution network.

For further pictures and information visit http://www.chemagen.com.

chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA or viral DNA/RNA is facilitated through chemagen’s proprietary M-PVA Magnetic Bead technology. chemagen’s high performance instrument is the chemagic Magnetic Separation Module I (chemagic MSM I). It enables automated separation of nucleic acids from sample volumes between 10 µl – 10 ml. Available kit applications include sample materials such as blood, serum/plasma, tissue, saliva, buccal swabs, amniotic fluid or feces. With the chemagic Prepito, chemagen offers a benchtop walk-away instrument relying upon the proven separation process for up to 600 µl blood and 1 - 12 samples in parallel.
Outstanding robustness, minimal hands on time and fast automated applications translate to the highest throughput and flexibility of your laboratory workflow.

Find further information at www.chemagen.com

chemagen USA, Inc.
67 Millbrook Street
Suit 522
Worcester, MA 01606
USA
+1 631 501 1879
office.usa@chemagen.com

Presscontact:
Stan Klein
General Manager
stan.klein@chemagen.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Swine Flu - Fast and Reliable Isolation of the Viral RNA here

News-ID: 95830 • Views:

More Releases from chemagen AG

chemagic 8 – a lab in a box
chemagic 8 – a lab in a box
Baesweiler, March 31st 2009, the chemagen AG, Germany, introduces the chemagic 8, a customized solution for the entire laboratory workflow process. This particular lab in a box facilitates primary sample handling via Nucleic Acid isolation to diagnostics and storage with minimized hands on time in a fully automated way – that´s the chemagic AID. The chemagic 8 combines 8 different features in an outstanding manner. The entire laboratory workflow processes

More Releases for MSM

CapU-MSM Agent Networking Summit 2022 kicks off at Chandigarh
International education service company M Square Media (MSM) and its partner, Canada-based Capilano University (CapU), hosted an "Agent Networking Summit 2022" on Wednesday, April 6, 2022 at The Lalit Chandigarh, Chandigarh in India. More than 200 international education stakeholders and agents joined the event facilitated by CapU's Director for International, Dr. Chris Bottrill. "We are beyond excited to host the first in-person Agent Networking event for CapU post-pandemic. Our team at
MSM Launches Advisory Board in Australia
International education platform M Square Media (MSM) is expanding its brand of quality education management in Australia with its new MSM Australia Advisory Board. The newly formed Advisory Board features highly respected members who have decades of experience in the international education sector. With this initiative, MSM, headquartered in Canada, is fortifying its presence in key markets such as Australia. It has formed an Advisory Board in the United
MSM Placebo Market Competitive Insights and Precise Outlook 2021-2027
Global MSM Placebo Market Size, Status and Forecast 2021-2026 The MSM Placebo Market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future roadmaps and its distributor analysis. The report provides pre COVID-19 historic data, the impact of the COVID-19,
11-30-2020 | Science & Education
MSM
Presentation College Inks Partnership with MSM to Increase International Student …
(November 2020) Presentation College has partnered with international education provider M Square Media (MSM) in its efforts to recruit more international students worldwide, drawing from a diverse community of students around the world. Founded in 1951, Presentation College is a private Catholic institution with a professions focus in the undergraduate programs, including health and natural sciences, nursing, and social and behavioral sciences. With its main campus in Aberdeen, South Dakota, Presentation
New singles released by MSM Music
Magnus Svanfeldt releases a new single "How Many Ways" featuring Ben Owen on fiddle, mando and guitar. The song is built around Ben's fiddle but based on a solid dance beat. It's a fun crossover between folk and dance. The song is released November 6th on Spotrify and other major platforms https://open.spotify.com/playlist/7gJpvWTY88halJd77LtUDp?si=iWsfL0I9T_aZYRtip2LszA Karlbergsvägen 53, Stockholm, Sweden magnus@msm-music.com Magnus Svanfeldt is singer-songwriter, artist, composer, producer and engineer based in Stockholm Sweden. Magnus Svanfeldt has previously
MSM Placebo Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the MSM Placebo market analysis, which studies the Dynamic Light Scattering (DLS) Analysis's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “ Global MSM Placebo Market Growth 2020-2025 ” Research Report categorizes the global Dynamic Light Scattering (DLS) Analysis market by key players, product type, applications and regions,etc. The report also covers